The purpose of this research is to understand how the combination of augmented reality technology and natural language commands can support anyone with programming a robot to perform a task. As robots enter our world, everyday users will need to tell a robot what to do, like an Amazon Alexa or Google Home. With today's robots, this is not possible. That is why we need your help!
Have you been recently diagnosed with follicular lymphoma (a type of non-Hodgkin lymphoma)? You may be able to take part in a research study to learn more about the safety and tolerability of an experimental drug called odronextamab.
The purpose of this research study is to explore benefits of workplace social connection following coffee meetups with colleagues. Must be a full-time UNC employee to participate.
Researchers at the University of North Carolina at Chapel Hill are studying innovative ways to promote healthy eating, physical activity, and weight loss in young adults using a smartphone app, digital health tools, and daily messaging. We are seeking volunteers to enroll in a 6-month research study that tests a smartphone-delivered weight loss program designed specifically for young adults.
In this study, we want to find out if a new treatment is helpful to couples in which both partners use substances and want to reduce their substance use together. This treatment combines couples therapy and substance use treatment to help couples work as a team around their substance use and build long-lasting ways to meaningfully experience life together.
Do you have metastatic or recurrent lung cancer? Have you already been treated with chemotherapy or immunotherapy? If so, you may qualify for the LungMap protocol, which will help us identify clinical trials you may be eligible for.
To evaluate the safety and efficacy of BLU-222 therapy in patients with advanced solid tumors.
Do you plan to undergo radiation therapy for a cancer in the abdomen or pelvic region? You may be able to take part in a research study to help us learn if a fatty acid supplement can improve quality of life by limiting GI upset during radiation therapy.
Have you been recently diagnosed with Acute Lymphoblastic Leukemia? If so, you may be able to take part in a research study to help us learn more about the effects of using Tyrosine Kinase Inhibitor (TKI), steroids and blinatumomab versus treatment with steroids, Tyrosine Kinase Inhibitor (TKI) and chemotherapy.
Do you have stage 1, HER2-positive breast cancer? Has your surgery already been completed? If so, you may be able to take part in a study to help us learn more about a combination of medications to treat your cancer.